AU Patent

AU2016278040B2 — Drug delivery and imaging chemical conjugate, formulations and methods of use thereof

Assigned to Nanophagix LLC · Expires 2019-07-04 · 7y expired

What this patent protects

The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated di…

USPTO Abstract

The present invention relates to compounds, and methods of use thereof, capable of entering macrophages. The invention further relates to compounds capable of modulating (for example inhibiting) the activity of the mammalian target of rapamycin (mTor), treating mTor-associated diseases, in particular, but not limited to, related to mTor in macrophages. The invention also relates to compounds capable of imaging mTor in a subject, in particular, but not limited to, mTor in macrophages.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016278040B2
Jurisdiction
AU
Classification
—
Expires
2019-07-04
Drug substance claim
No
Drug product claim
No
Assignee
Nanophagix LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.